Symbols / ADVM
ADVM Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-31 17:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - PR Newswire ue, 09 Dec 2025 08
- ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders - Business Wire Mon, 27 Oct 2025 07
- Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition - Quiver Quantitative ue, 09 Dec 2025 08
- Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - GlobeNewswire Mon, 01 Dec 2025 08
- Adverum stock soars after Lilly announces acquisition deal - Investing.com Fri, 24 Oct 2025 07
- Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal! - TechStock² Fri, 24 Oct 2025 07
- After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st Fri, 03 Oct 2025 07
- Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) - Yahoo Finance Sun, 21 Sep 2025 07
- Lilly to acquire Adverum for up to $12.47 per share in cash and CVRs (LLY:NYSE) - Seeking Alpha Fri, 24 Oct 2025 07
- Adverum Biotechnologies Completes Merger and Delisting - TipRanks ue, 09 Dec 2025 08
- Insider Buying: Laurent Fischer Acquires Shares of Adverum Biote - GuruFocus Mon, 08 Dec 2025 08
- Lilly to Acquire Adverum Biotechnologies - PR Newswire Fri, 24 Oct 2025 07
- ADVM Stock Price, News & Analysis - Stock Titan hu, 24 Apr 2025 17
- Insider Purchase: CEO of $ADVM Buys 117,614 Shares - Quiver Quantitative ue, 09 Dec 2025 08
- Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year - Yahoo Finance Fri, 03 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ADVM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|